Radiation Research · 1989 · 33 citations · 16 references
MedicineMedicinal ChemistryPharmacologyPharmacodynamicsRadiobiologyToxicodynamicsBiological Effects Of RadiationCellular Responses To HypoxiaHypoxia AdaptationRadiation SensitivityBone Marrow - Derived CellsHypoxiaHypoxia ModulationHypoxia RadiosensitivityRadioprotection MechanismsRadioprotective AgentsRadioprotective EffectsRadioprotective Mechanisms
The ability of thiol and non-thiol radioprotectors to induce hypoxia was determined using the binding of [3H]misonidazole by bone marrow cells as a measure of hypoxia. When administered at maximally radioprotective doses, four drugs (WR-2721, cysteamine, 5-hydroxytryptamine, and 16,16-dimethyl prostaglandin E2) significantly increased the amount of [3H]misonidazole bound by marrow cells, while no significant increase in binding was observed with three other agents (endotoxin, AET, superoxide dimutase). Doses of WR-2721 previously shown to provide suboptimal radioprotection did not significantly increase 3H-misonidazole binding. These results suggest that the physiological effects of some radioprotectors, that is, their ability to induce marrow hypoxia, may contribute to their efficacy in vivo.
16
The role of WR-2721 in radiotherapy and/or chemotherapy.
John M. Yuhas, James Spellman, Filip Čulo · PubMed · 1980 · 282 citations
J.W. Purdie, Elizabeth R. Inhaber, Henry Schneider et al. · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · 1983 · 131 citations